PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11303049-7	2001	In contrast, lisinopril infusion (5 and 10 mg/kg/30 min) affected the metabolism of both AcSDKP and angiotensin I.	Lisinopril	13-23	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	100-113	
27928554-7	2016	Further, Bleo inducetion of both AGT protein and of caspase-9 were prevented by the ACE inhibitor lisinopril.	Lisinopril	98-108	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	33-36	
27992423-8	2016	Further studies in melanoma cells (TM-5) showed that Ang-II induced cell proliferation through ACE activation, an event that could be inhibited either by ACE inhibitor (Lisinopril) or by the silencing of ACE.	Lisinopril	169-179	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	53-59	
26391272-6	2016	Kidneys from Agt-ASO-treated mice were not as enlarged and showed reduced cystic volume compared with lisinopril or control treatments.	Lisinopril	102-112	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	13-16	
24506807-9	2014	Treatment with lisinopril or lisW-S significantly reduced levels of AngII in kidneys (~4-fold; P<0.001).	Lisinopril	15-25	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	68-73